1. Home
  2. CDIO vs FBGL Comparison

CDIO vs FBGL Comparison

Compare CDIO & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • FBGL
  • Stock Information
  • Founded
  • CDIO 2017
  • FBGL 1996
  • Country
  • CDIO United States
  • FBGL Singapore
  • Employees
  • CDIO N/A
  • FBGL N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • FBGL Miscellaneous manufacturing industries
  • Sector
  • CDIO Health Care
  • FBGL Consumer Discretionary
  • Exchange
  • CDIO Nasdaq
  • FBGL Nasdaq
  • Market Cap
  • CDIO 7.0M
  • FBGL 7.8M
  • IPO Year
  • CDIO N/A
  • FBGL 2025
  • Fundamental
  • Price
  • CDIO $4.77
  • FBGL $0.66
  • Analyst Decision
  • CDIO Buy
  • FBGL
  • Analyst Count
  • CDIO 1
  • FBGL 0
  • Target Price
  • CDIO $60.00
  • FBGL N/A
  • AVG Volume (30 Days)
  • CDIO 102.5K
  • FBGL 143.2K
  • Earning Date
  • CDIO 05-15-2025
  • FBGL 01-01-0001
  • Dividend Yield
  • CDIO N/A
  • FBGL N/A
  • EPS Growth
  • CDIO N/A
  • FBGL N/A
  • EPS
  • CDIO N/A
  • FBGL N/A
  • Revenue
  • CDIO $19,902.00
  • FBGL $10,146,582.00
  • Revenue This Year
  • CDIO $1,434.82
  • FBGL N/A
  • Revenue Next Year
  • CDIO $4,661.91
  • FBGL N/A
  • P/E Ratio
  • CDIO N/A
  • FBGL N/A
  • Revenue Growth
  • CDIO N/A
  • FBGL N/A
  • 52 Week Low
  • CDIO $3.40
  • FBGL $0.44
  • 52 Week High
  • CDIO $53.10
  • FBGL $5.45
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 39.92
  • FBGL N/A
  • Support Level
  • CDIO $3.88
  • FBGL N/A
  • Resistance Level
  • CDIO $5.20
  • FBGL N/A
  • Average True Range (ATR)
  • CDIO 0.48
  • FBGL 0.00
  • MACD
  • CDIO 0.32
  • FBGL 0.00
  • Stochastic Oscillator
  • CDIO 68.25
  • FBGL 0.00

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.

Share on Social Networks: